Deferred Tax Assets, Valuation Allowance of IOVANCE BIOTHERAPEUTICS, INC. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
IOVANCE BIOTHERAPEUTICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • IOVANCE BIOTHERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $687,503,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

IOVANCE BIOTHERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $687,503,000 +$129,916,000 +23% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q4 2024 $557,587,000 +$110,734,000 +25% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q4 2023 $446,853,000 +$96,435,000 +28% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $350,418,000 +$82,949,000 +31% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $267,469,000 +$78,057,000 +41% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $189,412,000 +$60,692,000 +47% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $128,720,000 +$50,574,000 +65% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $78,146,000 +$30,297,000 +63% 31 Dec 2018 10-K 25 Feb 2020 2019 FY
Q4 2017 $47,849,000 +$6,447,000 +16% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 $41,402,000 +$22,056,000 +114% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q4 2015 $19,346,000 +$10,918,000 +130% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q4 2014 $8,428,000 +$4,748,978 +129% 31 Dec 2014 10-K 11 Mar 2016 2015 FY
Q4 2013 $3,679,022 +$10,636,151 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q4 2012 $6,957,129 31 Dec 2012 10-K 28 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.